Recent Articles

Funding to support continuity of Zero Ch...

A 20-year record of fast-tracking treatm...

Australian Cancer Research Foundation aw...

New drug yields extraordinary results in...

Leading medical research institute signs...

Researchers feature in The Australian â€...

Childhood Cancer Awareness Month

Grant supports ‘first in class’ trea...

Australian research paves way for new ca...

World-first study into precision medicin...

Minderoo Children’s Comprehensive Canc...

Cooper Rice-Brading Foundation funding t...

Precision medicine now available to all ...

NHMRC grants reward researchers with bri...

Professor Maria Kavallaris awarded the W...

Professor Michelle Haber honoured by The...

New funding announced for cutting-edge c...

Professor Michelle Haber awarded 2023 Si...

New $15m frontier technology centre to d...

The bittersweet story of childhood leuka...

Best in class: Good Design Award Accolad...

Professor David Ziegler awarded prestigi...

Join us this Childhood Cancer Awareness ...

Statement – Pareto Phone Data breach

Human Genome Project: 20 years later

Screening genes for the right treatment:...

New Deputy Directors appointed at Childr...

National clinical trial ecosystem will e...

Surviving sarcoma: Ashleigh’s story

Anya’s Wish – Sarcoma research to ma...

Immunotherapy for children with sarcoma

ZERO enrols 1000th child – a milestone...

Day in the life: brain cancer researcher

Australian nanomedicine research a ‘mi...

A new clinical trial for children with b...

Brain cancer in focus: An introduction

Exciting new research boosted by Cancer ...

Australian-led study paves way to more c...

Celebrating International Women's Day 20...

Zero Childhood Cancer precision medicine...

Main works underway on new $658 million ...

New clinical trial for fatal childhood b...

Research collaboration discovers how ret...

Inaugural ZERO symposium brings together...

Computational biology – harnessing dat...

A life should be long | Show your suppor...

Immunotherapy for kids with cancer: rapi...

Matching treatments to patients: the val...

Predicting cancer in children: rapidly-e...

Epigenetics: rapidly-evolving areas of r...

Childhood cancer researcher recognised f...

Genome sequencing provides new path to m...

$658M Sydney Children's Hospital and Min...

Professor Michelle Haber elected to dist...

New treatments for brain cancer – the ...

A personalised approach for children wit...

ACRF Launches Liquid Biopsy Program for ...

Minderoo Children’s Comprehensive Canc...

$185 million investment to fast-track tr...

Celebrating International Women's Day

Cancer Council NSW funds exciting new re...

Our new virtual lab tour

Closing the care gap | World Cancer Day ...

Improving the chances for children with ...

A new age in children’s healthcare for...

Madeleine's Diary of a Researcher

‘Moving the dial’ on treatment for c...

New DNA-based test on the horizon for ch...

Fast-tracking new treatments into clinic...

Professor Maria Kavallaris nominated for...

Join us this Childhood Cancer Awareness ...

Drug discovery in Australia strengthened...

Oncology One announces new drug discover...

Improving the outlook for babies with le...

Honours scholarship applications now ope...

Community funding to help kids with sarc...

Understanding high-risk leukaemia and ho...

Funding boost improves outlook for child...

In focus: Dr Orazio Vittorio

New drug combination found to be effecti...

Multimodal therapy may hold key to treat...

Australian researchers find new way to t...

Anya’s Wish: finding new treatments fo...

World-first discovery paves way to new c...

Celebrating International Women's Day 20...

A novel therapeutic approach to MYC-driv...

Sydney researchers identify/advance pote...

Cancer research today: Collaboration is ...

Cancer in children – what do the globa...

'Outstanding' childhood cancer scientist...

Opening the black box of childhood cance...

Leading childhood cancer researcher nomi...

Zero Childhood Cancer: How far have we c...

Awareness Wednesday: Discover and Transl...

Finding new treatments for those who nee...

Blocking copper uptake in tumour cells m...

Spotlight: Sarcoma in kids

Executive Director addresses largest can...

Targeting stem cells: the path to curing...

Australia to lead world-first trial in c...

Nanomedicine for brain cancer – a worl...

In focus: Brain cancer in kids

Science spotlight: Minimal Residual Dise...

Diary of a Researcher

$67m funding collaboration: All Australi...

A message from Professor Michelle Haber

Science spotlight: Metallomics

An update on our life-saving research

Children’s cancer researcher awarded N...

Research boosts progress towards persona...

'Liquid biopsy' - an exciting new test f...

International research collaboration rev...

New therapy shows ‘dramatic’ effect ...

Neuroblastoma research points to new pos...

Researchers find new way to target child...

Our New Research Structure

Awareness Wednesday: Immunotherapy

DIPG: Shining A Light On The Deadliest C...

Children’s Cancer Institute welcome th...

Our Supporters Turn Out in Record Number...

New gene found for a deadly childhood ca...

New Gene Found in Neuroblastoma Offers P...

Australian researchers find chink in the...

Anticancer Drug CBL0137 Highly Effective...

Therapy Developed For Alzheimers Could H...

New research paves the way for safer leu...

Science Spotlight: Leukaemia Stem Cells

Minderoo Foundation’s $5 million donat...

Endure For A Cure 2019 – The Power Of ...

Childhood cancer scientist rewarded for ...

Leading children’s cancer scientist aw...

Dr Angelica Merlot awarded 2019 NSW Youn...

World-Class Children's Comprehensive Can...

Meet new Team Leader, Dr Charles de Bock

Our researchers combine an old drug with...

Australian Scientists Discover a Potenti...

Maria Kavallaris receives Order of Austr...

Fundamental mechanism behind chemotherap...

Partnerships: Cancer Therapeutics CRC

How Targeting Copper Levels in Tumours C...

New Drug OBI-3424 An ‘Orphan Drug’ T...

New imaging method could help treat and ...

Childhood Cancer Awareness Month

Awareness Wednesday: Drug Discovery

Awareness Wednesday: Cancer Genomics

Media Release: 'Zero Childhood Cancer' C...

Tracking cancer with gold-coated nanopar...

A little girl’s legacy: Olivia Lambert...

Media Release: Prime Minister announces ...

A global effort to improve childhood can...

Let’s talk about nanomedicine

Nano-stars – targeting a deadly childh...

We’ve created our road map for the nex...

Forging new alliances to tackle childhoo...

Neuroblastoma researchers build bridges ...

My first Mother’s Day without Byron

$1 million funding boost for Zero Childh...

The past, present and future for young A...

Dr Toby Trahair childhood cancer researc...

My Daughter's Cancer Journey

New hope for children's brain cancer

Reining In A Runaway Gene In Neuroblasto...

Zero Childhood Cancer national clinical ...

Sydney researchers find a way to target ...

It’s in the Delivery: Researchers Find...

Meet a Researcher: Q&A with Dr Marion Le...

Opening doors to a world of scientific e...

VR helps scientists ‘walk’ through c...

How specific DNA ‘microdeletions’ he...

Lexie's Christmas

A very techie Christmas

How do clinical trials work?

Meet A Researcher: Q&A With Biljana Dume...

We made great strides with childhood leu...

Potential Leukaemia Drug Excites Interna...

Fighting Fund For Brain Cancer Aims To D...

Resistance is Futile: The MRP1 Story

How a Dad's Insights can Help Research

Awareness Wednesday: the Future of Child...

Awareness Wednesday: going into clinic

Children with most aggressive cancers to...

Zero Childhood Cancer personalised medic...

Awareness Wednesday: Testing our results

Awareness Wednesday: Starting with the B...

When I grow up, I want to cure cancer

Meet a scientist keeping drug discovery ...

How we’re stopping neuroblastoma’s b...

Eureka! Prof Michelle Haber a finalist i...

Sights set on an aggressive childhood le...

Childhood cancers defy current understan...

Changing the future for children with br...

Explainer: what is nanomedicine and how ...

Clinical trials and Lind’s ‘acid tes...

The microbe that started a revolution

Zero Childhood Cancer update

How parent's insights help my research

New leukaemia subtype found by DNA test

Facts & figures draw a picture of childh...

Joining the dots to find neuroblastoma d...

Meet a Researcher: Q&A with Dr Alvin Kam...

Neuroblastoma treatment search: polyamin...

Glowing report: firefly gene shows hidde...

Taking a walk inside a cancer cell

An Aussie anti-cancer drug success story

Nixon's Christmas

NSW to become world leader in paediatric...

Big data wrangling: Bioinformatics and c...

Profiler: what makes cancer cells’ met...

Zero Childhood Cancer program taking sha...

We need better treatment for childhood c...

$20M from Federal Government for Persona...

Four seasons in one lab

Skeletons in cancer fight

Professor Maria Kavallaris elected AAHMS...

It’s our party: 40 years of research

Children’s Cancer Institute celebrates...

Awareness Wednesday: Brain cancers

Targeting high-risk leukaemia subtypes

Awareness Wednesday: Leukaemia

Awareness Wednesday: Neuroblastoma

Awareness Wednesday: Childhood cancer fa...

Robots play major role in tailoring trea...

Meet our researchers: Prof Maria Kavalla...

Prime Minister announces major funding c...

A way to target the Achilles heel of neu...

Zero Childhood Cancer program aims to pu...

Deputy Director appointed AM

Michelle Haber inaugural fellow AAHMS

Children’s Cancer Institute and Sydney...

Children’s Cancer Institute’s Execut...

30 years closer: Children’s Cancer Ins...
